Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 8,505,229	$ 14,969,743	$ 15,928,552	$ 21,153,251
General and administrative	1,663,503	3,038,064	4,667,639	6,248,420
Loss from operations	(10,168,732)	(18,007,807)	(20,596,191)	(27,401,671)
Other income (expense):
Interest income	872,038	1,637,836	1,853,525	3,448,105
Interest expense	(470,618)	(477,601)	(954,147)	(976,128)
Total other income, net	401,420	1,160,235	899,378	2,471,977
Net loss	$ (9,767,312)	$ (16,847,572)	$ (19,696,813)	$ (24,929,694)
Net loss per share - basic	$ (0.16)	$ (0.28)	$ (0.33)	$ (0.42)
Net loss per share - diluted	$ (0.16)	$ (0.28)	$ (0.33)	$ (0.42)
Weighted average common shares outstanding - basic	60,045,530	59,414,489	59,966,841	59,414,489
Weighted average common shares outstanding - diluted	60,045,530	59,414,489	59,966,841	59,414,489